Nothing Special   »   [go: up one dir, main page]

CERN Accelerating science

CERN Document Server 3 εγγραφές βρέθηκαν  Η έρευνα πήρε 1.19 δευτερόλεπτα. 
1.
“Particle therapy - future for the Baltic states?” – synthesis of the expert workshop report / Paļskis, Kristaps (Riga Tech. U. ; CERN) ; Korobeinikova, Erika ; Bogorada-Saukuma, Dace ; Camarda, Anna Maria (CNAO, Milan) ; Taylor, Rebecca (CERN ; Imperial Coll., London) ; Benedetto, Elena ; Mamis, Edgars (CERN ; Latvia U.) ; Radziņa, Maija ; Ērglis, Andrejs (Latvia U.) ; Adliene, Diana et al.
Background Baltic States remains one of the few regions in the Europe without a dedicated particle therapy center. An initiative since 2021 has been started by CERN Baltic Group on a novel particle therapy center development in the region in partnership with CERN NIMMS collaboration. [...]
2024 - 8 p. - Published in : Health Technol. 14 (2024) 965-972 Fulltext: PDF;
2.
Target Development towards First Production of High-Molar- Activity $^{44g}$Sc and $^{47}$Sc by Mass Separation at CERN-MEDICIS / Mamis, Edgars (CERN ; Latvia U.) ; Duchemin, Charlotte (CERN) ; Berlin, Valentina (CERN) ; Bernerd, Cyril (CERN) ; Bovigny, Mathieu (CERN) ; Chevallay, Eric (CERN) ; Crepieux, Bernard (CERN) ; Gadelshin, Vadim Maratovich (Mainz U., Inst. Phys.) ; Heinke, Reinhard (CERN) ; Hernandez, Ronaldo Mendez (CERN ; Havana, ISCTN) et al.
The radionuclides 43Sc,  44g/mSc, and 47Sc can be produced cost-effectively in sufficient yield for medical research and applications by irradiating  natTi and  natV target materials with protons. Maximizing the production yield of the therapeutic 47Sc in the highest cross section energy range of 24–70 MeV results in the co-production of long-lived, high-γ-ray-energy 46Sc and 48Sc contaminants if one does not use enriched target materials. [...]
2024 - 28 p. - Published in : Pharmaceuticals 17 (2024) 390 Fulltext: PDF;
3.
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go? / Radzina, Maija (Latvia U. ; CERN) ; Saule, Laura (Latvia U.) ; Mamis, Edgars (Latvia U. ; CERN) ; Koester, Ulli (Laue-Langevin Inst.) ; Cocolios, Thomas Elias (Leuven U.) ; Pajuste, Elina (Latvia U.) ; Kalnina, Marika (Unlisted) ; Palskis, Kristaps (CERN ; Riga Tech. U.) ; Sawitzki, Zoe (Leuven U.) ; Talip, Zeynep (PSI, Villigen) et al.
Background In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventional radionuclides for medical and translational research. The aim of this article is to introduce readers with current status of novel radionuclides in Europe. Main body A consortium questionnaire was disseminated through the PRISMAP consortium and user community, professional associations and preclinical/clinical end users in Europe and the current status of clinical end-users in nuclear medicine were identified. [...]
2023 - 16 p. - Published in : EJNMMI Radiopharm. Chem. 8 (2023) 27 Fulltext: PDF;

Δείτε ακόμη: παρόμοια ονόματα συγγραφέων
3 Mamis, E
Ενδιαφέρεστε να ενημερώνεστε για νέα αποτελέσματα σχετικά με το ερώτημα αυτό;
Δημιουργήστε ένα προσωπικό email alert ή εγγραφείτε στο RSS feed.
Δεν βρήκατε αυτό που αναζητούσατε; Δοκιμάστε την έρευνά σας σε άλλους servers:
Mamis, Edgars σε Amazon
Mamis, Edgars σε CERN EDMS
Mamis, Edgars σε CERN Intranet
Mamis, Edgars σε CiteSeer
Mamis, Edgars σε Google Books
Mamis, Edgars σε Google Scholar
Mamis, Edgars σε Google Web
Mamis, Edgars σε IEC
Mamis, Edgars σε IHS
Mamis, Edgars σε INSPIRE
Mamis, Edgars σε ISO
Mamis, Edgars σε KISS Books/Journals
Mamis, Edgars σε KISS Preprints
Mamis, Edgars σε NEBIS
Mamis, Edgars σε SLAC Library Catalog
Mamis, Edgars σε Scirus